Tekmira Pharmaceuticals Corporation (TKMR) Stock Dives After Earnings

Mark Melin

Published onAugust 13, 2014

Updated on May 13, 2021

Investors in Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TSE:TKM) might be greeted with a rude awakening Thursday morning, as the company missed its earnings estimates and badly whiffed on revenue. Shares of the stock were halted late in the afternoon pending the earnings announcement. In after hours trading, the stock is sharply lower, moving back to test support near the stock's 200 day moving average, which is currently at $15.87.

Table of Contents

Tekmira Pharmaceuticals reports second quarter losses

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TSE:TKM) reported second quarter earnings per share with a loss of -$0.28, which was $0.02 worse than the analyst estimate loss of -$0.26. Revenue for the quarter took the steepest hit, coming in in...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Mark Melin

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Tekmira Pharmaceuticals Corporation (TKMR) Stock Dives After Earnings

Tekmira Pharmaceuticals reports second quarter losses

Login required to continue reading.

Get Your Business News